CDSCO Issues Alert on Novo Nordisk Products Following Thefts

Strategic Insights -

The Central Drugs Standard Control Organisation (CDSCO) has issued an alert to healthcare professionals and patients due to the theft of Novo Nordisk products during transit. The stolen products include semaglutide, a weight loss drug, and insulin Aspart and Degludec, used for diabetes treatment. The regulator has instructed patients to purchase these products from authorized sources only, with proper invoices, and has asked state drug control offices to maintain a strict vigil on the movement of these products in the market.

Key Takeaways:

  • The CDSCO has issued an alert to healthcare professionals and patients regarding the theft of Novo Nordisk products, including semaglutide, insulin Aspart, and Degludec.
  • Novo Nordisk informed the regulator about the theft of its products during transit from its Bhiwandi Hub to various locations.
  • The stolen products are rDNA origin injectables that require storage at a temperature of 2-8°C to maintain quality and safety.
  • Patients have been advised to procure these products from authorized sources only, with proper invoices.
  • State drug control offices have been instructed to maintain a strict vigil on the movement of these products in the market.
  • The regulator intends to take necessary action under the Drugs and Cosmetics Act, 1940, in case of non-compliance.
  • The products in question include semaglutide, a weight loss drug, and insulin Aspart and Degludec, used for diabetes treatment.

Statistics:

  • The stolen products include rDNA origin injectables that require storage at 2-8°C.
  • The formulations are supposed to be maintained at 2°C to 8°C to ensure quality and safety.
  • Failure to store these products at the specified temperature range may impact the quality and safety of the medication.
  • Patients have been advised to procure these products from authorized sources only, with proper invoices.

Sources:

  • The Hindu | "CDSCO issues alert on Novo Nordisk products following thefts"
  • Business Standard | "CDSCO alerts healthcare professionals on Novo Nordisk products after thefts"